COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Ankasa Regenerative Therapeutics develops proprietary WNT3A stem-cell activator formulations for localized tissue and bone repair, initially targeting spinal fusion with preclinical efficacy in animal models and planned clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors